S
Susana Cedres Perez
Researcher at Hebron University
Publications - 10
Citations - 389
Susana Cedres Perez is an academic researcher from Hebron University. The author has contributed to research in topics: Internal medicine & Immunotherapy. The author has an hindex of 3, co-authored 7 publications receiving 298 citations.
Papers
More filters
Journal ArticleDOI
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.
Michele Maio,Arnaud Scherpereel,Luana Calabrò,Joachim G.J.V. Aerts,Susana Cedres Perez,Alessandra Bearz,Kristiaan Nackaerts,Dean A. Fennell,Dariusz M. Kowalski,Anne S. Tsao,Paul D. Taylor,Federica Grosso,Scott J. Antonia,Anna K. Nowak,Anna K. Nowak,Maria Taboada,Martina Puglisi,Paul K. Stockman,Hedy L. Kindler +18 more
TL;DR: The DETERMINE study investigated the effects of the cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody tremelimumab in patients with previously treated advanced malignant mesothelioma and overall survival was overall survival in the intention-to-treat population.
Journal ArticleDOI
Tremelimumab as second- or third-line treatment of unresectable malignant mesothelioma (MM): Results from the global, double-blind, placebo-controlled DETERMINE study.
Hedy L. Kindler,Arnaud Scherpereel,Luana Calabrò,Joachim G.J.V. Aerts,Susana Cedres Perez,Alessandra Bearz,Kristiaan Nackaerts,Dean A. Fennell,Dariusz M. Kowalski,Anne S. Tsao,Paul D. Taylor,Federica Grosso,Scott J. Antonia,Anna K. Nowak,Ramy Ibrahim,Maria Taboada,Martina Puglisi,Paul K. Stockman,Michele Maio +18 more
TL;DR: Single-arm Phase 2 trials of T using 2 different doses and schedules achieved responses and durable disease control in MM pts with unresectable pleural or peritoneal MM.
Journal ArticleDOI
P3.02c-063 Lactate Dehydrogenase (LDH) as a Surrogate Biomarker to Checkpoint-Inhibitors for Patient with Advanced Non–Small-Cell Lung Cancer (NSCLC): Topic: IT Biomarkers
Am Martinez De Castro,Alejandro Navarro,Susana Cedres Perez,A. Martinez,N. Pardo,Alberto Hernando,Carolina Ortiz,Fabiola Amair,M. Biosca,Juan Aguilar-Company,Eulalia Scheenaard,Sergi Recasens,LLuisa Carbonell,Andrea Retter,S. Sanchez Martinez,Adelaida Piera,Sonia Valverde,Lidia Velez,Silvia García Matas,Marta Vilaro,Enriqueta Felip +20 more
Journal ArticleDOI
Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC)
Susana Cedres Perez,I. Quispe,Pablo Martinez,Marina Longo,Eva Rodríguez,César Serrano,Eva Muñoz,Esther Pallisa,Enriqueta Felip +8 more
TL;DR: A good correlation between clinical and pathologic tumour size by CT scan is found and possible prognostic factors in surgically resected pathologic stage IA and IB NSCLC patients are determined.
Journal ArticleDOI
OA22.01 STELLAR - Interim Results of a Phase 2 Trial of TTFields with Chemotherapy for First Line Treatment of Malignant Mesothelioma
Federica Grosso,Jarek Mądrzak,Rodryg Ramlau,Susana Cedres Perez,Lucio Crinò,Antonio Chella,Manlio Mencoboni,Birgitta Hiddinga,Giovanni Luca Ceresoli +8 more